
This study assessed the predictive performance of various biomarkers, including glycosylated fibronectin (GlyFn), for screening the risk of PE and GH at ≥37 weeks gestation. The results showed that combining maternal risk factors with MAP, PlGF, and sFLT-1 had the highest detection rate for PE within 3 weeks or at any time after screening. Screening during the third trimester was more effective than early screening at 11+0 to 13+6 weeks.
Like
Save
Share